IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM
IMS-IMWG 2025共识基因组分期可预测基于达雷妥尤单抗的四联疗法治疗新诊断多发性骨髓瘤的疗效。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025018537
Maclachlan, Kylee H; Tan, Carlyn R; Shekarkhand, Tala; Rueda, Colin; Derkach, Andriy; Hashmi, Hamza; Hassoun, Hani; Shah, Urvi A; Hultcrantz, Malin; Lesokhin, Alexander M; Mailankody, Sham; Maura, Francesco; Merz, Maximillian; Firestone, Ross; Jurgens, Eric M; Miller, Kevin C; Rajeeve, Sridevi; Giralt, Sergio; Shah, Gunjan L; Scordo, Michael; Landau, Heather J; Zhang, Yanming; Cimera, Robert; Arcila, Maria E; Korde, Neha; Usmani, Saad Z